MedPath

Intervention for Smoking Cessation in Pre-Surgical Patients.

Not Applicable
Recruiting
Conditions
Smoking
Smoking Cessation
Surgical Procedure, Unspecified
Interventions
Behavioral: Brief intervention for smoking cessation
Behavioral: Intensive intervention for smoking cessation
Registration Number
NCT05961813
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question\[s\] it aims to answer are:

* Evaluate the efficacy of intensive pre surgical intervention to quit smoking compared to a brief intervention

* Evaluate the implementation of this protocol.

Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.

Detailed Description

1. Subject recruitment in pre surgical anesthesiology consults, data collection and randomization within 48 hours of said visit.

2. Subjects in the intensive intervention group will be sent to a specialized Preventive Medicine consult for smoking cessation, completing 6 visits (2 before surgical intervention, 4 visits withint the following 12 months). Subjects in the control group will receive brief advice on quitting smoking through a phone call the the same day randomization is performed. Both groups will receive follow up calls at months 1, 3, 6, and 12, after surgical intervetion. All patients will have their smoking habits evaluated and the relevant data about the surgical intervention collected the day of the intervention.

3. At month 7 adecuacy of the protocol will be evaluated to assess if any modifications are necessary.

4. Data entry and quality control of the database will be performed periodically for the duration of the study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
232
Inclusion Criteria
  • Patients must 18 years old or older, and be able to consent.
  • Surgery programmed for at least 4 weeks after inclusion in the study.
  • Smokers
Exclusion Criteria
  • Pregnancy
  • Already under treatment for smoking cessation
  • Inability to consent due to cognitive impairment or language barrier.
  • Non-primary knee or hip replacement surgery
  • Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control group in protesic implant orthopedic surgeryBrief intervention for smoking cessation58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will receive a brief intervention for smoking cessation.
Intervention group in general and urological surgeryIntensive intervention for smoking cessation58 patients programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will be sent to a specialized preventive medicine consult to quit smoking.
Intervention group in protesic implant orthopedic surgeryIntensive intervention for smoking cessation58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will be sent to a specialized preventive medicine consult to quit smoking.
Control group in general and urological surgeryBrief intervention for smoking cessation58 programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will receive a brief intervention for smoking cessation.
Primary Outcome Measures
NameTimeMethod
Tobacco useEvaluated at 1, 3, 6, and 12 months after surgical intervention

Change in self reported tobacco use (smoking)

Secondary Outcome Measures
NameTimeMethod
Changes in rate of different type of tobbaco product usersEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Cigarettes, cigars, rolling tobacco, etc.

Changes in disposition to smoking cessationEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Prochaska and Di Clemente's model (pre contemplation, contemplation, preparation, action, maintenance or relapse)

Surgery durationDay of intervention

Time spent in the operation room

Changes in concentration of exhaled CO measured with a CO-oximeterEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

A patient will be considered as an active tobacco user if more than 6 of carboxyhemoglobin particles per million are found through the use of a CO-oximeter

Changes in tobacco use patternEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Amount and frequency (daily, weekly, sporadically)

Changes in Motivation levelEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Richmond's test (\<3 no motivation; 4-5 doubtful motivation; 6-7 moderate motivation; 8-10 high motivation)

Number of patients with surgical complicatoinsHospitalization period and 90 days after surgical intervention.

Complications will be classified as respiratory, cardiovascular, surgical wound and complications, mortality

Need of blood transfusionDay of intervention

Volume of blood transfused during surgery

Hospitalization durationDays from admitting until discharge.

Number of days of hospitalization after surgery.

Changes in degree of nicotine dependencyEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Fagerström test \[low dependency (0-3), medium dependency (4-6), y high dependency (7-10)\]

Changes in self-efficacyEvaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

Albert Bandura's social cognitive theory

Need of new hospitalizations12 months after surgical intervention.

Number of times patient is admitted to the hospital during follow up

Trial Locations

Locations (1)

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Catalunya, Spain

© Copyright 2025. All Rights Reserved by MedPath